Cancer Investigation

Journal

Publication Venue For

  • A multicenter phase II trial of carboplatin and cetuximab for treatment of advanced nonsmall cell lung cancer.  28:208-215. 2010
  • TAE226 inhibits human neuroblastoma cell survival.  26:145-151. 2008
  • Role of neurokinin-1 receptor antagonists in chemotherapy-induced emesis: Summary of clinical trials.  22:569-576. 2004
  • A phase I trial of olanzapine (zyprexa) for the prevention of delayed emesis in cancer patients: A hoosier oncology group study.  22:383-388. 2004
  • Health literacy and shared decision making for prostate cancer patients with low socioeconomic status.  19:684-691. 2001
  • Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.  15:297-303. 1997
  • Tumor cell invasion of basement membrane in vitro is regulated by amino acids.  14:6-18. 1996
  • Host response to myeloma: Effect of syngeneic spleen cells on the growth and functionof MOPC 104e myeloma in vitro.  8:17-25. 1990
  • Immunoregulation of murine plasmacytoma II. Target selectivity of anomalous killer cells and role of immune t cells for the induction.  7:27-38. 1989
  • Immunoregulation of murine plasmacytoma i. Generation of anomalous killer cells in vitro by cocultivation with MOPC 104e.  7:17-26. 1989
  • Host response to myeloma: I. Induction of cytotoxic and suppressor t cells by in vivo immunization with MOPC 104e plasmacytoma.  6:29-37. 1988
  • Induction of the plateau phase and rescue of MOPC 104e by nonspecific immunization.  4:525-533. 1986
  • Host regulation of MOPC 104e plasmacytoma after reduction of tumor burden by total body irradiation.  3:217-223. 1985
  • Intestinal absorption of nutrients in animals dosed orally with retinoids: Considerations for chemopreventive studies.  3:243-248. 1985
  • International Standard Serial Number (issn)

  • 0735-7907
  • Electronic International Standard Serial Number (eissn)

  • 1532-4192